EFFICACY OF KUSHMANDA GHRITA AS AN ADD ON DRUG INGENERALIZED TONIC CLONIC SEIZURES - A RANDOMIZEDCONTROLLED CLINICAL TRIA

KLE UNIVERSITY0 个研究点目标入组 40 人开始时间: 待定最近更新: 2022年10月17日

试验速览

暂无简介。

•1.Those with an established diagnosis of Epilepsy with generalized tonic-clonic seizures
•2. Patients having occurrence of at least one seizure during previous three months
•3. 18 to 60 years of age irrespective of gender and socio-economic status.
•4. Patients having regular treatment since last 6 months and with Levetiracetam without
•adjustments to medication for past 3 months.

•1. Recent history of alcoholism and drug abuse.
•2. Patients with uncontrolled diabetes mellitus, hypertension, congenital abnormalities, hepatic,
•renal, cardiac or endocrine disease.
•3. Mental retardation, infectious diseases of brain, vascular causes, toxic causes and metabolic causes of seizures.
•4. Episode of status epilepticus within the past 3 months.
•5. Psychiatric disorders like Schizophrenia, Psychosis, depression, suicidal thoughts etc
•6. Pregnancy and lactating mother.

发起方